This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1vr1
From Proteopedia
|
Specifity for Plasminogen Activator Inhibitor-1
Contents |
Overview
Substitution of the native variable region-1 (VR1/37-loop) of thrombin by, the corresponding VR1 of tissue-type plasminogen activator, (thrombin-VR1(tPA)) increases the rate of inhibition by plasminogen, activator inhibitor type 1 (PAI-1) by three orders of magnitude, and is, thus sufficient to confer PAI-1 specificity to a heterologous serine, protease. A structural and kinetical approach to establish the function of, the VR1 loop of t-PA in the context of the thrombin-VR1(tPA) variant is, described. The crystal structure of thrombin-VR1(tPA) was resolved and, showed a conserved overall alpha-thrombin structure, but a partially, disordered VR1 loop as also reported for t-PA. The contribution of a, prominent charge substitution close to the active site was studied using, charge neutralization variants thrombin-E39Q(c39) and, thrombin-VR1(tPA)-R304Q(c39), resulting in only fourfold changes in the, PAI-1 inhibition rate. Surface plasmon resonance revealed that the, affinity of initial reversible complex formation between PAI-1 and, catalytically inactive Ser195-->Ala variants of thrombin and, thrombin-VR1(tPA) is only increased fivefold, i.e. KD is 652 and 128 nM, for thrombin-S195A and thrombin-S195A-VR1(tPA), respectively. We, established that the partition ratio of the suicide substrate reaction, between the proteases and PAI-1 was largely unaffected in any variant, studied. Hirugen allosterically decreases the rate of thrombin inhibition, by PAI-1 2.5-fold and of thrombin-VR1(tPA) 20-fold, by interfering with a, unimolecular step in the reaction, not by decreasing initial complex, formation or by altering the stoichiometry. Finally, kinetic modeling, demonstrated that acylation is the rate-limiting step in thrombin, inhibition by PAI-1 (k approximately 10(-3) s(-1)) and this kinetic block, is alleviated by the introduction of the tPA-VR1 into thrombin (k>1, s(-1)). We propose that the length, flexibility and different charge, architecture of the VR1 loop of t-PA invoke an induced fit of the reactive, center loop of PAI-1, thereby enhancing the rate of acylation in the, Michaelis complex between thrombin-VR1(t-PA) and PAI-1 by more than two, orders of magnitude.
Disease
Known diseases associated with this structure: Dysprothrombinemia OMIM:[176930], Hyperprothrombinemia OMIM:[176930], Hypoprothrombinemia OMIM:[176930]
About this Structure
1VR1 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop., Dekker RJ, Eichinger A, Stoop AA, Bode W, Pannekoek H, Horrevoets AJ, J Mol Biol. 1999 Oct 29;293(3):613-27. PMID:10543954
Page seeded by OCA on Mon Nov 12 19:44:40 2007
